Imunon, Inc. - Common Stock — Quarterly Cash Flow (NASDAQ:IMNN) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 6.86 M8.79 M8.99 M12.29 M8.02 M Total liabilities 6.41 M6.13 M4.91 M5.23 M4.66 M Total equity 452.03 K2.66 M4.08 M7.06 M3.36 M Total liabilities & shareholders' equities 6.86 M8.79 M8.99 M12.29 M8.02 M Total debt ————— Net debt —————

News

Imunon, Inc. (IMNN) Presents at Life Sciences Virtual Investor Forum - Slideshow (NASDAQ:IMNN) 2026-06-26

Imunon, Inc. (IMNN) Q1 2026 Earnings Call Transcript

Imunon stock price target raised to $25 from $14 at H.C. Wainwright

Imunon stock rises following strategic restructuring to focus on Phase 3 trial

Brookline Capital lowers Imunon stock price target to $16 on offering dilution

IMUNON raises $7 million in registered direct offering

Earnings call transcript: Imunon Q3 2025 sees stock volatility post-call

Imunon, Inc. (IMNN) Discusses IMNN-001 Immunotherapy Progress and Milestones in OVATION 3 Ovarian Cancer Study Transcript

IMUNON provides updates on ovarian cancer immunotherapy program

IMUNON to present new data on ovarian cancer therapy at SITC meeting

IMUNON begins Phase 3 trial of ovarian cancer immunotherapy

IMUNON reports positive data from ovarian cancer immunotherapy study